USE OF FUSED HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS FOR THE TREATMENT OF SKIN CONDITIONS OR CANCER
申请人:Arexis AB
公开号:EP1631295A2
公开(公告)日:2006-03-08
Use of heterocyclic compounds as scce inhibitors
申请人:Linschoten Marcel
公开号:US20060258651A1
公开(公告)日:2006-11-16
The present invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More particularly, the invention relates to the use of compounds with the formula (I) or (II) for treatment of certain diseases, in particular skin diseases such as pruirtus, as well as cancer such as ovarian cancer.
US7872052B2
申请人:——
公开号:US7872052B2
公开(公告)日:2011-01-18
[EN] USE OF HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS<br/>[FR] UTILISATION DE COMPOSES HETEROCYCLIQUES EN TANT QU'INHIBITEURS DE SCCE
申请人:AREXIS AB
公开号:WO2004108139A2
公开(公告)日:2004-12-16
The present invention relates to heterocyclic inhibitors of stratum corneum chymotryptic enzyme (SCCE). More particularly, the invention relates to the use of compounds with the formula (I) or (II) for treatment of certain diseases, in particular skin diseases such as pruirtus, as well as cancer such as ovarian cancer.
Recyclable Heterogeneous Palladium-Catalyzed Carbonylative Cyclization of 2-Iodoanilines with Aryl Iodides Leading to 2-Arylbenzoxazinones
作者:Zhaotao Xu、Bin Huang、Zebiao Zhou、Mingzhong Cai
DOI:10.1055/s-0039-1690265
日期:2020.2
A highly efficient and practical heterogeneous palladium-catalyzedcarbonylative coupling of 2-iodoanilines with aryl iodides has been developed. The reaction occurs smoothly in toluene at 110 °C with N,N-diisopropylethylamine as base under carbon monoxide (5 bar) and offers a general and powerful tool for the construction of various valuable 2-arylbenzoxazinones with excellent atom-economy, high functional